Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Therapy Class

  2.3.2 Market Size By Disease Stage

  2.3.3 Market Size By Route of Administration

 2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Active Pharmaceutical Ingredient (API) & Excipient Suppliers

  3.4.2 Prostate Cancer Therapeutics Manufacturers

  3.4.3 Pharmaceutical Distributors & Specialty Pharmacy Providers

  3.4.4 Hospitals, Oncology Clinics & Patients

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Epidemiology & Disease Burden Analysis

  4.1.1 Overview

  4.1.2 Prostate Cancer Incidence & Prevalence Analysis, By Region, 2022–2035

  4.1.3 Disease Stage Distribution & Patient Pool Assessment

 4.2 Treatment Landscape & Clinical Adoption Analysis

  4.2.1 Overview

  4.2.2 Therapy Adoption Trends By Therapy Class

  4.2.3 Treatment Pathway Analysis By Disease Stage & End User

 4.3 Innovation & Clinical Pipeline Assessment

  4.3.1 Overview

  4.3.2 Late-Stage Clinical Pipeline Analysis

  4.3.3 Biomarker & Precision Medicine Trends

  4.3.4 Emerging Radioligand & Combination Therapy Developments

5. Prostate Cancer Therapeutics Market Segmental Analysis & Forecast, By Therapy Class, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Hormonal Therapy & Androgen-Receptor Pathway Inhibitors

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Chemotherapy

 5.4 Targeted Therapy & PARP Inhibitors

 5.5 Radioligand & Radiopharmaceutical Therapy

 5.6 Immunotherapy

6. Prostate Cancer Therapeutics Market Segmental Analysis & Forecast, By Disease Stage, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Metastatic Castration-Resistant Prostate Cancer

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Metastatic Hormone-Sensitive Prostate Cancer

 6.4 Non-Metastatic Castration-Resistant Prostate Cancer

 6.5 Localized High-Risk & Biochemical Recurrent Disease

7. Prostate Cancer Therapeutics Market Segmental Analysis & Forecast, By Route of Administration, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oral

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Intravenous Infusion

 7.4 Radiopharmaceutical Infusion

 7.5 Subcutaneous & Intramuscular Injection

8. Prostate Cancer Therapeutics Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals & Cancer Centers

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Specialty Oncology & Urology Clinics

 8.4 Retail & Specialty Pharmacies

 8.5 Nuclear Medicine & Radioligand Centers

 8.6 Others

9. Prostate Cancer Therapeutics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Prostate Cancer Therapeutics Market Size & Forecast, By Therapy Class, 2022–2035

 9.2.3 Prostate Cancer Therapeutics Market Size & Forecast, By Disease Stage, 2022–2035

 9.2.4 Prostate Cancer Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.2.5 Prostate Cancer Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.2.6 Prostate Cancer Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Prostate Cancer Therapeutics Market Size & Forecast, By Therapy Class, 2022–2035

 9.3.3 Prostate Cancer Therapeutics Market Size & Forecast, By Disease Stage, 2022–2035

 9.3.4 Prostate Cancer Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.3.5 Prostate Cancer Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.3.6 Prostate Cancer Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Prostate Cancer Therapeutics Market Size & Forecast, By Therapy Class, 2022–2035

 9.4.3 Prostate Cancer Therapeutics Market Size & Forecast, By Disease Stage, 2022–2035

 9.4.4 Prostate Cancer Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.4.5 Prostate Cancer Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.4.6 Prostate Cancer Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Prostate Cancer Therapeutics Market Size & Forecast, By Therapy Class, 2022–2035

 9.5.3 Prostate Cancer Therapeutics Market Size & Forecast, By Disease Stage, 2022–2035

 9.5.4 Prostate Cancer Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.5.5 Prostate Cancer Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.5.6 Prostate Cancer Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Prostate Cancer Therapeutics Market Size & Forecast, By Therapy Class, 2022–2035

 9.6.3 Prostate Cancer Therapeutics Market Size & Forecast, By Disease Stage, 2022–2035

 9.6.4 Prostate Cancer Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.6.5 Prostate Cancer Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.6.6 Prostate Cancer Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Therapy Class/Service & Disease Stage Benchmarking

  10.4.1 Therapy Class/Service Specifications & Features By Key Players

  10.4.2 Therapy Class/Service Heatmap By Key Players

  10.4.3 Disease Stage Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 Johnson & Johnson

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Therapy Class/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

  10.6.2 Astellas Pharma Inc.

10.6.3 Pfizer Inc.

10.6.4 Bayer AG

10.6.5 AstraZeneca PLC

10.6.6 Novartis AG

10.6.7 Sanofi

10.6.8 Merck & Co., Inc.

10.6.9 Tolmar Inc.

10.6.10 Ferring Pharmaceuticals

10.6.11 Ipsen

10.6.12 Bristol Myers Squibb

10.6.13 Clarity Pharmaceuticals

10.6.14 Telix Pharmaceuticals

10.6.15 Eli Lilly and Company

10.6.16 Lantheus Holdings, Inc.

10.6.17 Blue Earth Therapeutics

10.6.18 Curium Pharma

10.6.19 Amgen Inc.

10.6.20 Exelixis, Inc.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures